NCT03523338 2025-12-10An Expanded Access Protocol for Apalutamide Treatment of Participants With Non-Metastatic Castration-Resistant Prostate CancerAragon Pharmaceuticals, Inc.No longer available
NCT05064306 2025-08-01131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young AdultsMemorial Sloan Kettering Cancer CenterNo longer available